Try our Advanced Search for more refined results

September 11, 2020

OREXO AB et al v. SUN PHARMACEUTICALS INDUSTRIES LIMITED et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. July 03, 2023

    Sun Infringes Orexo's Opioid Addiction Drug IP, Judge Rules

    A New Jersey federal judge has sided with drugmaker Orexo in a patent suit lodged against competitor Sun Pharmaceuticals over generic versions of opioid addiction treatment Zubsolv, upholding the asserted biotechnology and deeming it infringed by the challenged generics.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login